XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Note 2 - Acquisitions (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2017
Notes Tables |
Business Acquisition, Pro Forma Information [Table Text Block] |
|  | Year Ended |
|  | June 30, |
|  | 2017 |  |  | 2016 |
Net sales |  | $ | 564,220 |  |  | $ | 523,840 |
Net income |  |  | 99,380 |  |  |  | 110,536 |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] |
|  | Zephyrus |  |  | Cliniqa |  |  | CyVek |  |  | Protein Simple |  |  | Novus |
Current assets |  | $ | 56 |  |  | $ | 11,926 |  |  | $ | 1,206 |  |  | $ | 19,660 |  |  | $ | 10,739 |
Equipment |  |  | 32 |  |  |  | 1,436 |  |  |  | 971 |  |  |  | 1,983 |  |  |  | 1,266 |
Other long-term assets |  |  | - |  |  |  | 58 |  |  |  | 19 |  |  |  | 554 |  |  |  | 40 |
Intangible Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Developed technology |  |  | 8,300 |  |  |  | 18,000 |  |  |  | 20,200 |  |  |  | 39,200 |  |  |  | 5,010 |
Trade name |  |  | - |  |  |  | 1,100 |  |  |  | 100 |  |  |  | 36,100 |  |  |  | 5,300 |
Customer relationships |  |  | - |  |  |  | 27,000 |  |  |  | 600 |  |  |  | 101,600 |  |  |  | 14,400 |
Non-compete agreements |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 200 |  |  |  | - |
Goodwill |  |  | 8,686 |  |  |  | 42,669 |  |  |  | 91,658 |  |  |  | 134,074 |  |  |  | 28,408 |
Total assets acquired |  |  | 17,074 |  |  |  | 102,189 |  |  |  | 114,754 |  |  |  | 333,371 |  |  |  | 65,163 |
Liabilities |  |  | 54 |  |  |  | 1,508 |  |  |  | 1,965 |  |  |  | 11,644 |  |  |  | 2,166 |
Deferred income taxes, net |  |  | 2,521 |  |  |  | 17,793 |  |  |  | (438 | ) |  |  | 21,674 |  |  |  | 2,875 |
Net assets |  |  | 14,500 |  |  |  | 82,888 |  |  |  | 113,227 |  |  |  | 300,053 |  |  |  | 60,122 |
Less fair-value of previous investment |  |  | - |  |  |  | - |  |  |  | 18,300 |  |  |  | - |  |  |  | - |
Net assets acquired |  | $ | 14,500 |  |  | $ | 82,888 |  |  | $ | 94,927 |  |  | $ | 300,053 |  |  | $ | 60,122 |
Cash paid, net of cash acquired |  | $ | 8,000 |  |  | $ | 82,888 |  |  | $ | 59,927 |  |  | $ | 300,053 |  |  | $ | 60,122 |
Note Payable |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Contingent consideration payable |  |  | 6,500 |  |  |  | - |  |  |  | 35,000 |  |  |  | - |  |  |  | - |
Net purchase price |  | $ | 14,500 |  |  | $ | 82,888 |  |  | $ | 94,927 |  |  | $ | 300,053 |  |  | $ | 60,122 |
Space [Member] |
Notes Tables |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] |
|  | Final Opening Balance Sheet Allocation |
Current assets, net of cash |  | $ | 2,128 |
Equipment |  |  | 159 |
Intangible assets: |  |  |  |
Customer relationships |  |  | 6,769 |
Goodwill |  |  | 3,517 |
Total assets acquired |  |  | 12,573 |
Liabilities |  |  | 1,444 |
Deferred income taxes, net |  |  | 2,125 |
Net assets acquired |  | $ | 9,003 |
Cash paid, net of cash acquired |  | $ | 6,747 |
Consideration payable |  |  | 2,256 |
Net purchase price |  | $ | 9,003 |
Advanced Cell Diagnostics (ACD) [Member] |
Notes Tables |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] |
|  | Preliminary Allocation at Acquisition Date |  |  | Adjustments to F air Value |  |  | Updated Opening Balance Sheet Allocation at June 30, 2017 |
Current assets, net of cash |  | $ | 25,196 |  |  | $ | (9,372 | ) |  | $ | 15,824 |
Equipment |  |  | 2,757 |  |  |  |  |  |  |  | 2,757 |
Other long-term assets |  |  | 3,812 |  |  |  |  |  |  |  | 3,812 |
Intangible assets: |  |  |  |  |  |  |  |  |  |  |  |
Developed technology |  |  | 107,000 |  |  |  | 43,000 |  |  |  | 150,000 |
Trade name |  |  | 17,000 |  |  |  | 4,900 |  |  |  | 21,900 |
Customer relationships |  |  | 77,000 |  |  |  | (70,700 | ) |  |  | 6,300 |
Non-compete agreement |  |  | 200 |  |  |  | (200 | ) |  |  | - |
Goodwill |  |  | 133,780 |  |  |  | 10,187 |  |  |  | 143,967 |
Total assets acquired |  |  | 366,745 |  |  |  | (22,185 | ) |  |  | 344,560 |
Liabilities |  |  | 3,591 |  |  |  | 588 |  |  |  | 4,179 |
Deferred income taxes, net |  |  | 78,761 |  |  |  | (26,018 | ) |  |  | 52,743 |
Net assets acquired |  | $ | 284,393 |  |  |  | 3,245 |  |  | $ | 287,638 |
Cash paid, net of cash acquired |  | $ | 246,193 |  |  |  | 845 |  |  | $ | 247,038 |
Consideration payable |  |  | - |  |  |  | 3,600 |  |  |  | 3,600 |
Fair value contingent consideration |  |  | 38,200 |  |  |  | (1,200 | ) |  |  | 37,000 |
Net purchase price |  | $ | 284,393 |  |  |  | 3,245 |  |  | $ | 287,638 |

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=tech_SpaceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=tech_AdvancedCellDiagnosticsACDMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |